1. Assessment of the In Vitro Antifungal Activity of SCY-078 Against a Collection of C. parapsilosis Clinical Isolates. (4th October 2017) Authors: Barat, Stephen; Angulo, David; Borroto-Esoda, Katyna; Ghannoum, Mahmoud Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Pharmacokinetics and Drug‐Drug Interaction Potential for Coadministered SCY‐078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus. Issue 1 (27th June 2018) Authors: Wring, Stephen; Murphy, Gail; Atiee, George; Corr, Christy; Hyman, Michele; Willett, Michael; Angulo, David Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 1(2019) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FDA Public Workshop Summary—Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs. (15th October 2021) Authors: O'Shaughnessy, Elizabeth; Yasinskaya, Yuliya; Dixon, Cheryl; Higgins, Karen; Moore, Jason; Reynolds, Kellie; Ampel, Neil M; Angulo, David; Blair, Janis E; Catanzaro, Antonino; Galgiani, John N; Garvey, Edward; Johnson, Royce; Larwood, David J; Lewis, Gareth; Purdie, Rob; Rex, John H; Shubitz, Lis... Journal: Clinical infectious diseases Issue: Volume 74:Number 11(2022) Page Start: 2061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions. (10th May 2018) Authors: Wring, Stephen; Murphy, Gail; Atiee, George; Corr, Christy; Hyman, Michele; Willett, Michael; Angulo, David Journal: Journal of clinical pharmacology Issue: Volume 58:Number 10(2018) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral Ibrexafungerp Outcomes in Subjects With Refractory Vulvovaginal Candidiasis From an Open-Label Study (FURI) [A122]. (May 2022) Authors: Goje, Oluwatosin; King, Thomas; Angulo, David; Azie, Nkechi Journal: Obstetrics and gynecology Issue: Volume 139(2022)Supplement 1 Page Start: 36S Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis. (1st September 2020) Authors: Azie, Nkechi; Angulo, David; Dehn, Barbara; Sobel, Jack D. Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 9(2020) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P056 Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI). (20th September 2022) Authors: Prattes, Juergen; King, Thomas; Azie, Nkechi; Angulo, David Journal: Medical mycology Issue: Volume 60(2022)supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI). (20th September 2022) Authors: Prattes, Juergen; King, Thomas; Azie, Nkechi; Angulo, David Journal: Medical mycology Issue: Volume 60(2022)supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SCY-078 Demonstrates Significant Antifungal Activity in a Murine Model of Invasive Aspergillosis. (4th October 2017) Authors: Borroto-Esoda, Katyna; Barat, Stephen; Angulo, David; Holden, Kirsty; Warn, Peter Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SCY-078 Demonstrates Significant Tissue Penetration in Rats and Mice Following Oral or IV Administration. (4th October 2017) Authors: Barat, Stephen; Borroto-Esoda, Katyna; Angulo, David Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗